HI
MED icon

HBK Investments’s Medifast MED Stock Holding History

HBK Investments’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-34,485
Closed -$4.4M – 878
2019
Q1 		$4.4M Sell
34,485
-12,294
-26% -$1.56M 0.04% 351
2018
Q4 		$5.85M Buy
46,779
+13,676
+41% +$2.34M 0.06% 247
2018
Q3 		$7.33M Buy
+33,103
New +$6.71M 0.06% 208

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

HBK Investments's MED Position: Q2 2019 in Review

HBK Investments sold out of Medifast (MED) in Q2 2019, closing a stake of 34,485 shares — an estimated $4.4M sold.

HBK Investments first reported a position in MED in Q3 2018 and held it in 3 quarters. The position peaked at $7.33M in Q3 2018. 251 funds tracked by Wall St. Rank hold MED as of Q2 2019.

  • HBK Investments reported no remaining Medifast position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 34,485 Medifast shares in Q2 2019, an estimated $4.4M.
  • HBK Investments first reported a position in Medifast in Q3 2018 and held it in 3 quarters.
  • HBK Investments's Medifast position peaked at $7.33M in Q3 2018.
  • 251 funds tracked by Wall St. Rank held Medifast as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.